(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 3.19% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.32%.
Teleflex's revenue in 2026 is $2,255,361,000.On average, 15 Wall Street analysts forecast TFX's revenue for 2026 to be $90,705,303,907, with the lowest TFX revenue forecast at $87,849,693,115, and the highest TFX revenue forecast at $94,671,430,007. On average, 15 Wall Street analysts forecast TFX's revenue for 2027 to be $94,195,494,875, with the lowest TFX revenue forecast at $90,863,948,951, and the highest TFX revenue forecast at $98,796,201,151.
In 2028, TFX is forecast to generate $98,439,249,802 in revenue, with the lowest revenue forecast at $94,274,817,397 and the highest revenue forecast at $103,476,229,949.